Tenax Therapeutics Statistics

Total Valuation

TENX has a market cap or net worth of $15.24 million. The enterprise value is $6.13 million.

Market Cap	15.24M
Enterprise Value	6.13M

Important Dates

The next estimated earnings date is Friday, November 15, 2024, after market close.

Earnings Date	Nov 15, 2024
Ex-Dividend Date	n/a

Share Statistics

TENX has 3.41 million shares outstanding. The number of shares has increased by 766.16% in one year.

Shares Outstanding	3.41M
Shares Change (YoY)	+766.16%
Shares Change (QoQ)	+60.63%
Owned by Insiders (%)	0.24%
Owned by Institutions (%)	22.62%
Float	2.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.99
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.10, with a Debt / Equity ratio of 0.03.

Current Ratio	6.10
Quick Ratio	5.39
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-529.08

Financial Efficiency

Return on equity (ROE) is -113.79% and return on invested capital (ROIC) is -71.73%.

Return on Equity (ROE)	-113.79%
Return on Assets (ROA)	-66.09%
Return on Capital (ROIC)	-71.73%
Revenue Per Employee	n/a
Profits Per Employee	-$2.10M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -71.35% in the last 52 weeks. The beta is 2.15, so TENX's price volatility has been higher than the market average.

Beta (5Y)	2.15
52-Week Price Change	-71.35%
50-Day Moving Average	3.83
200-Day Moving Average	4.22
Relative Strength Index (RSI)	60.76
Average Volume (20 Days)	83,835

Short Selling Information

The latest short interest is 21,026, so 0.62% of the outstanding shares have been sold short.

Short Interest	21,026
Short Previous Month	29,110
Short % of Shares Out	0.62%
Short % of Float	0.80%
Short Ratio (days to cover)	0.68

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-13.04M
Pretax Income	-10.10M
Net Income	-12.57M
EBITDA	-13.03M
EBIT	-13.04M
Earnings Per Share (EPS)	-$13.33

Full Income Statement

Balance Sheet

The company has $9.38 million in cash and $278,802 in debt, giving a net cash position of $9.11 million or $2.67 per share.

Cash & Cash Equivalents	9.38M
Total Debt	278,802
Net Cash	9.11M
Net Cash Per Share	$2.67
Equity (Book Value)	8.88M
Book Value Per Share	4.53
Working Capital	8.87M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-11.45M
Capital Expenditures	n/a
Free Cash Flow	-11.45M
FCF Per Share	-$3.36

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TENX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-766.16%
Shareholder Yield	-766.16%
Earnings Yield	-82.51%
FCF Yield	-75.16%

Analyst Forecast

The average price target for TENX is $20.67, which is 362.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.67
Price Target Difference	362.42%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 3, 2024. It was a reverse split with a ratio of 0.0125:1.

Last Split Date	Jan 3, 2024
Split Type	Reverse
Split Ratio	0.0125:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1